Home / In One

In One

Invectys’ CARGo project: $14.2M 2020 CPRIT Award

Invectys well poised to bring its anti-HLA-G CAR-T cells to clinical trials …

Read more

HLA-G platform

Harnessing the potential of a novel immune checkpoint with HLA-G platform Invectys exploits a powerful immune checkpoint named HLA-G. It is found mostly at the fetal-maternal…

Read more

DNA Vaccination

The main product of Invectys is a DNA vaccine targeting Telomerase…

Read more


The telomerase enzyme functions as part of a large ensemble of proteins and RNA called the telomerase ribonucleoprotein complex.…

Read more